CD123 Redirected T Cells

· University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD123 Redirected T Cells, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: CD123 Redirected T Cells for AML in Pediatric Subjects [Phase 1]